Cellular and Gene Therapy
Cell therapy is therapy during which cellular material is injected into a patient. Nowadays 2 distinct classes of cell therapy are: the first class is cell therapy in mainstream drugs. This is often the topic of intense research and the basis of potential therapeutic benefit. The second class is in alternative medicine and perpetuates the practice of injecting animal materials to cure disease. The target of cell therapy is to revive the lost function instead of manufacturing a brand-new organ that may cause duplicity and undesirable effects. Gene therapy is that the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy may be a way to fix a genetic drawback at its supply. The polymers are either translated into proteins, interfere with target gene expression, or presumably correct genetic mutations. The foremost common kind uses a deoxyribonucleic acid that encodes a useful, therapeutic gene to exchange a mutated gene. The compound molecule is packaged along with a "vector” that carries the molecule within cells. The vector incorporates genes into chromosomes. The expressed nucleases then knock out and replace genes within the body. These therapies have had good results, though the deficiency of the beginning material could represent a significant limitation.
- Cell-Based Assays
- Cell Therapy Products
- Vectors Used In Gene Therapy
- Viral Gene Therapy
- Gene Therapy For Diseases
- Development & Production
- Risks and Benefits
- Key Aspects for Consideration in Regulatory Guidance
Related Conference of Cellular and Gene Therapy
19th International Conference on Human Genomics and Genomic Medicine
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
17th International Conference on Human Genetics and Genetic Diseases
Cellular and Gene Therapy Conference Speakers
Recommended Sessions
- Advancement in Cancer Treatments
- Anti-Aging Medicine
- Artificial Organs
- Biobanking
- Biomaterial and Bioengineering
- Cancer Cell Biology
- Cell Biology
- Cellular and Gene Therapy
- Epigenetics and Epigenome
- Ethical Issues and Marketing Status Around the Globe
- Precision Medicine
- Regenerative Medicine
- Stem Cells and its Applications
- Tissue Culture and Preservation
- Tissue Engineering
- Tissue Repair and Regeneration
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)

